Brian French is a partner and member of the firm’s Government Investigations and White Collar Defense team. He represents clients in government investigations, enforcement actions, and litigation, mostly involving the life sciences and healthcare industries. Brian began his career at Gulfcoast Legal Services in Clearwater, Florida, representing low-income children and families in civil rights, education, and disability-related matters.
I represent a range of healthcare organizations, life sciences companies, executives, and employees in government investigations and related criminal proceedings and civil litigation brought by the U.S. Department of Justice, U.S. Attorney’s Offices, state attorneys general, and qui tam relators. In the healthcare field, I’ve represented hospitals, home health and hospice organizations, skilled nursing facilities, dialysis providers, anesthesia providers, pain clinics, clinical laboratories, durable medical equipment companies, and physician groups in federal grand jury investigations, False Claims Act investigations and litigation, enforcement actions by the U.S. Department of Health and Human Services, Office of Inspector General, audits by Medicare and Medicaid contractors, and voluntary self-disclosures to government regulators. I’ve also represented many pharmaceutical, biotechnology, and medical device companies, as well as individuals, in government enforcement matters and litigation involving alleged off-label promotion and Anti-Kickback Statute violations, relationships with charitable patient assistance programs, consumer protection matters, and pricing and reimbursement issues.
I provide proactive compliance advice to clients in the healthcare and life sciences industries. I partner with clients in assessing their key risk areas and help them develop compliance strategies and programs that reflect the specific needs and goals of their organizations. I work with clients to ensure that their proposed business arrangements comply with federal and state regulations and collaborate with them in developing alternative solutions when necessary. In the life sciences field, I advise clients on a wide range of issues, such as appropriate product and service promotion, co-payment assistance programs, proper financial arrangements and collaborations between and among industry and providers, and the Physician Payment Sunshine Act (Open Payments) and related transparency issues. Finally, I help conduct regulatory due diligence reviews in merger and acquisition transactions.
This article mentions NP for representing Halma PLC in its acquisition of TeDan, a group of companies that develop, manufacture, and supply medical devices to surgeons. The NP deal team was led by New York City Corporate partner Dan Belostock and also included Corporate partners Alexandra Lopez-Casero and Thomas McCord of Boston, Kevin Grant of New York City, and Shahzad Malik of Los Angeles; Boston Government Investigations & White-Collar Defense partners Hannah Bornstein and Brian French; Boston Labor & Employment partner Jeff Gilbreth; Los Angeles Intellectual Property partner Seth Levy; Rochester Privacy & Technology counsel Jenny Holmes and Boston Corporate counsel David Crosby; Corporate associates Brian Kenney of Washington, DC and Tim Sharkey of New York City; Chicago IP associates Ben Rosborough and Eliana Torres; Los Angeles Labor & Employment associate Alice Kwak; Chicago IP senior paralegal Tim Fiester; and Chicago Corporate paralegal Astrid McGruder.
This article, which follows up on ex-Theranos CEO Elizabeth Holmes’ sentencing, quotes from a related client alert written by Boston Government Investigations and White-Collar Defense partners Brian French and Hannah Bornstein, deputy leader of the practice group.
Boston Government Investigations & White Collar Defense partner and a member of the firm’s Life Sciences practice Brian French discusses high-stakes cases for the health industry including those involving False Claims Act litigation and reimbursement disputes.
Boston Government Investigations & White Collar Defense partner and member of the Life Sciences practice Brian French discusses recent False Claims Act lawsuits likely to reshape a litigation landscape particularly in health care and life sciences.
U.S. Court of Appeals, First Circuit
U.S. Court of Appeals, Eleventh Circuit
U.S. District Court, District of Massachusetts
U.S. District Court, Middle District of Florida
Boston College Law School, J.D.
University of Massachusetts, Amherst, B.A., cum laude, Phi Beta Kappa
Brian is a former co-chair of the Health Care Fraud Subcommittee of the American Bar Association’s Criminal Litigation Committee. He was also a founding member, and served as regional vice-chair, of the Public Schools Committee of the ABA’s Section on Individual Rights and Responsibilities. He was also a contributing author to the Criminal and Enforcement Litigation section of the ABA’s 2006, 2007, and 2008 editions of the Annual Review of Developments in Business and Corporate Litigation. Brian is a former member of the Summer Jobs Program Steering Committee and the Public Policy Subcommittee of the Criminal Law Section of the Boston Bar Association.
In the community, Brian served on the Advisory Board for the Boys and Girls Clubs of Boston’s YouthConnect program, an advocacy and intervention program for at-risk youth. He is a former member of the Board of Directors and treasurer of Brookline Youth Hockey, and a past member of the Dana-Farber Leadership Council, where he served for four years as co-chair of the DFLC Walk Committee. Brian served on the Board of Directors of both the Silvio O. Conte Education Foundation and Families for Depression Awareness.
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe